Indications for Unicompartmental Knee Arthroplasty and Rationale for Robotic Arm–Assisted Technology
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Resection Arthroplasty for Failed Shoulder Arthroplasty
J Shoulder Elbow Surg (2013) 22, 247-252 www.elsevier.com/locate/ymse Resection arthroplasty for failed shoulder arthroplasty Stephanie J. Muh, MDa, Jonathan J. Streit, MDb, Christopher J. Lenarz, MDa, Christopher McCrum, BSc, John Paul Wanner, BSa, Yousef Shishani, MDa, Claudio Moraga, MDd, Robert J. Nowinski, DOe, T. Bradley Edwards, MDf, Jon J.P. Warner, MDg, Gilles Walch, MDh, Reuben Gobezie, MDi,* aCase Shoulder and Elbow Service, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, OH, USA bDepartment of Orthopaedics, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Cleveland, OH, USA cCase Western Reserve University School of Medicine, Cleveland, OH, USA dDepartment of Orthopedic Surgery, Clinica Alemana Santiago, Santiago, Chile eOrthoNeuro, New Albany, OH, USA fFondren Orthopedic Group, Houston, TX, USA gHarvard Shoulder Service, Massachusetts General Hospital, Boston, MA, USA hCentre Orthopedique Santy, Shoulder Unit, Lyon, France iThe Cleveland Shoulder Institute, University Hospitals of Cleveland, Cleveland, OH, USA Background: As shoulder arthroplasty becomes more common, the number of failed arthroplasties requiring revision is expected to increase. When revision arthroplasty is not feasible, resection arthroplasty has been used in an attempt to restore function and relieve pain. Although outcomes data for resection arthroplasty exist, studies comparing the outcomes after the removal of different primary shoulder arthro- plasties have been limited. Materials and methods: This was a retrospective multicenter review of 26 patients who underwent resection arthroplasty for failure of a primary arthroplasty at a mean follow-up of 41.8 months (range, 12-130 months). Resection arthroplasty was performed for 6 failed total shoulder arthroplasties (TSAs), 7 failed hemiarthro- plasties, and 13 failed reverse TSAs. -
2017 American College of Rheumatology/American Association
Arthritis Care & Research Vol. 69, No. 8, August 2017, pp 1111–1124 DOI 10.1002/acr.23274 VC 2017, American College of Rheumatology SPECIAL ARTICLE 2017 American College of Rheumatology/ American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty SUSAN M. GOODMAN,1 BRYAN SPRINGER,2 GORDON GUYATT,3 MATTHEW P. ABDEL,4 VINOD DASA,5 MICHAEL GEORGE,6 ORA GEWURZ-SINGER,7 JON T. GILES,8 BEVERLY JOHNSON,9 STEVE LEE,10 LISA A. MANDL,1 MICHAEL A. MONT,11 PETER SCULCO,1 SCOTT SPORER,12 LOUIS STRYKER,13 MARAT TURGUNBAEV,14 BARRY BRAUSE,1 ANTONIA F. CHEN,15 JEREMY GILILLAND,16 MARK GOODMAN,17 ARLENE HURLEY-ROSENBLATT,18 KYRIAKOS KIROU,1 ELENA LOSINA,19 RONALD MacKENZIE,1 KALEB MICHAUD,20 TED MIKULS,21 LINDA RUSSELL,1 22 14 23 17 ALEXANDER SAH, AMY S. MILLER, JASVINDER A. SINGH, AND ADOLPH YATES Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to the recommendations within this guideline to be volun- tary, with the ultimate determination regarding their application to be made by the physician in light of each patient’s individual circumstances. Guidelines and recommendations are intended to promote benefi- cial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed and endorsed by the ACR are subject to periodic revision as warranted by the evolution of medi- cal knowledge, technology, and practice. -
ERAS for Hip and Knee (THA and TKA) Arthroplasty – a Need to Look Beyond LOS
ASERalert November 2016 | Volume 1, Issue 1 ERAS for Hip and Knee (THA and TKA) Arthroplasty – A Need to Look Beyond LOS OFFICIAL also in this issue PUBLICATION OF ERAS for Total Enhanced ERAS for Spine Joint Arthroplasty: Recovery for Surgery: A New Past, Present and Orthopedic Frontier ASER ALERT • VOLUME 1, ISSUE 1 • aserhq.org Future Surgery 1 ANNUAL CONGRESS OF ENHANCED RECOVERY AND 2017 PERIOPERATIVE MEDICINE APRIL 27TH-29TH, 2017 HYATT REGENCY WASHINGTON ON CAPITOL HILL 400 NEW JERSEY AVE NW, WASHINGTON, D.C. 20001 For more information please visit www.aserhq.org 2 ASER ALERT • VOLUME 1, ISSUE 1 • aserhq.org Board of Directors President’s Message Officers By Tong J (TJ) Gan, MD, MHS, FRCA, President President Tong J (TJ) Gan, MD, MHS, FRCA President-Elect Julie Thacker, MD t is my great pleasure to announce Vice-President the inaugural issue of the ASER Timothy Miller MB, ChB, FRCA Newsletter. Founded in 2014, Treasurer ASER is a multi-specialty nonprofit Roy Soto, MD Iorganization with an international Secretary membership and is dedicated to the Stefan D. Holubar MD, MS, FACS, FASCRS practice of enhanced recovery in the perioperative patient through education Directors and research. We are experiencing a period of tremendous expansion and Keith A. (Tony) Jones, MD growth, as is evidenced by the great Anthony Senagore, MD interest to implement the enhanced Maxime Cannesson, MD, PhD recovery pathway in hospitals around Terrence Loftus, MD, MBA, FACS the country. Andrew Shaw MB, FRCA, FFICM, FCCM Desiree Chappel, CRNA The ASER Mission is to advance the practice of perioperative enhanced recovery and to contribute to its pathways. -
Patient Education Total Knee Arthroplasty
Patient Education Total Knee Arthroplasty Explanation of Diagnosis and Procedure The knee is the largest joint in the body. Normal knee function is required to perform most everyday activities. The knee is made up of the lower end of the thighbone (femur), which rotates on the upper end of the shin bone (tibia), and the kneecap (patella), which slides in a groove on the end of the femur. Large ligaments attach to the femur and tibia to provide stability. The long thigh muscles give the knee strength. Normal Knee Anatomy The joint surfaces where these three bones touch are covered with articular cartilage, a smooth substance that cushions the bones and enables them to move easily. Medical Illustration © 2012 Nucleus Medical Media, Inc. All remaining surfaces of the knee are covered by a thin, smooth tissue liner called the synovial membrane. This membrane releases a special fluid that lubricates the knee, reducing friction to nearly zero in a healthy knee. Normally, all of these components work in harmony. But disease or injury can disrupt this harmony, resulting in pain, muscle weakness, and reduced function. Knee with Arthritis The most common cause of chronic knee pain and disability is arthritis. Osteoarthritis, rheumatoid arthritis, and traumatic arthritis are the most common forms of this disease. • Osteoarthritis usually occurs in people 50 years of age and older and often in individuals with a family history of arthritis. The cartilage that cushions the bones of the knee softens and wears away. The bones then rub against one another, causing knee pain and stiffness. • Rheumatoid arthritis is a disease in which the synovial membrane becomes thickened and inflamed, producing too much synovial fluid that overfills the joint space. -
Knee Osteoarthritis
Patrick O’Keefe, MD Knee Osteoarthritis Overview What is knee osteoarthritis? Osteoarthritis, also known as Osteoarthritis is the most common type of knee arthritis. "wear and tear" arthritis, is a common problem for many A healthy knee easily bends and straightens because of a people after they reach middle smooth, slippery tissue called articular cartilage. This age. Osteoarthritis of the knee substance covers, protects, and cushions the ends of the is a leading cause of disability leg bones that form your knee. in the United States. It develops slowly and the pain it Between your bones, two c-shaped pieces of meniscal causes worsens over time. cartilage act as "shock absorbers" to cushion your knee Although there is no cure for joint. Osteoarthritis causes cartilage to wear away. osteoarthritis, there are many treatment options available. How it happens: Osteoarthritis occurs over time. When the Using these, people with cartilage wears away, it becomes frayed and rough. Moving osteoarthritis are able to the bones along this exposed surface is painful. manage pain, stay active, and live fulfilling lives. If the cartilage wears away completely, it can result in bone rubbing on bone. To make up for the lost cartilage, Questions the damaged bones may start to grow outward and form painful spurs. If you have any concerns or questions after your surgery, Symptoms: Pain and stiffness are the most common during business hours call symptoms of knee osteoarthritis. Symptoms tend to be 763-441-0298 or Candice at worse in the morning or after a period of inactivity. 763-302-2613. -
Juvenile Arthritis and Exercise Therapy: Susan Basile
Mini Review iMedPub Journals Journal of Childhood & Developmental Disorders 2017 http://www.imedpub.com ISSN 2472-1786 Vol. 3 No. 2: 7 DOI: 10.4172/2472-1786.100045 Juvenile Arthritis and Exercise Therapy: Susan Basile Current Research and Future Considerations Department of Kinesiology and Health, Georgia State University, IL, USA Abstract Corresponding author: Susan Basile Juvenile Idiopathic Arthritis (JIA) is a chronic condition affecting significant numbers of children and young adults. Symptoms such as pain and swelling can [email protected] lead to secondary conditions such as altered movement patterns and decreases in physical activity, range of motion, aerobic capacity, and strength. Exercise therapy has been an increasingly utilized component of treatment which addresses both Department of Kinesiology and Health, primary and secondary symptoms. The objective of this paper was too give an Georgia State University, USA. overview of the current research on different types of exercise therapies, their measurements, and outcomes, as well as to make recommendations for future Tel: 630-583-1128 considerations and research. After defining the objective, articles involving patients with JIA and exercise or physical activity-based interventions were identified through electronic databases and bibliographic hand search of the Citation:Basile S. Juvenile Arthritis and existing literature. In all, nineteen articles were identified for inclusion. Studies Exercise Therapy: Current Research and involved patients affected by multiple subtypes of arthritis, mostly of lower body Future Considerations. J Child Dev Disord. joints. Interventions ranged from light systems of movement like Pilates to an 2017, 3:2. intense individualized neuromuscular training program. None of the studies exhibited notable negative effects beyond an individual level, and most produced positive outcomes, although the significance varied. -
Variation in the Initial Treatment of Knee Monoarthritis in Juvenile Idiopathic Arthritis: a Survey of Pediatric Rheumatologists in the United States and Canada
Variation in the Initial Treatment of Knee Monoarthritis in Juvenile Idiopathic Arthritis: A Survey of Pediatric Rheumatologists in the United States and Canada TIMOTHY BEUKELMAN, JAMES P. GUEVARA, DANIEL A. ALBERT, DAVID D. SHERRY, and JON M. BURNHAM ABSTRACT. Objective. To characterize variations in initial treatment for knee monoarthritis in the oligoarthritis sub- type of juvenile idiopathic arthritis (OJIA) by pediatric rheumatologists and to identify patient, physi- cian, and practice-specific characteristics that are associated with treatment decisions. Methods. We mailed a 32-item questionnaire to pediatric rheumatologists in the United States and Canada (n = 201). This questionnaire contained clinical vignettes describing recent-onset chronic monoarthritis of the knee and assessed physicians’ treatment preferences, perceptions of the effective- ness and disadvantages of nonsteroidal antiinflammatory drugs (NSAID) and intraarticular corticos- teroid injections (IACI), proficiency with IACI, and demographic and office characteristics. Results. One hundred twenty-nine (64%) questionnaires were completed and returned. Eighty-three per- cent of respondents were board certified pediatric rheumatologists. Respondents’ treatment strategies for uncomplicated knee monoarthritis were broadly categorized: initial IACI at presentation (27%), initial NSAID with contingent IACI (63%), and initial NSAID with contingent methotrexate or sulfasalazine (without IACI) (10%). Significant independent predictors for initial IACI were believing that IACI is more effective than NSAID, having performed > 10 IACI in a single patient at one time, and initiating methotrexate via the subcutaneous route for OJIA. Predictors for not recommending initial or contin- gent IACI were believing that the infection risk of IACI is significant and lacking comfort with per- forming IACI. Conclusion. There is considerable variation in pediatric rheumatologists’ initial treatment strategies for knee monoarthritis in OJIA. -
Joint Pain Or Joint Disease
ARTHRITIS BY THE NUMBERS Book of Trusted Facts & Figures 2020 TABLE OF CONTENTS Introduction ............................................4 Medical/Cost Burden .................................... 26 What the Numbers Mean – SECTION 1: GENERAL ARTHRITIS FACTS ....5 Craig’s Story: Words of Wisdom What is Arthritis? ...............................5 About Living With Gout & OA ........................ 27 Prevalence ................................................... 5 • Age and Gender ................................................................ 5 SECTION 4: • Change Over Time ............................................................ 7 • Factors to Consider ............................................................ 7 AUTOIMMUNE ARTHRITIS ..................28 Pain and Other Health Burdens ..................... 8 A Related Group of Employment Impact and Medical Cost Burden ... 9 Rheumatoid Diseases .........................28 New Research Contributes to Osteoporosis .....................................9 Understanding Why Someone Develops Autoimmune Disease ..................... 28 Who’s Affected? ........................................... 10 • Genetic and Epigenetic Implications ................................ 29 Prevalence ................................................... 10 • Microbiome Implications ................................................... 29 Health Burdens ............................................. 11 • Stress Implications .............................................................. 29 Economic Burdens ........................................ -
Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes Within an Inflammation Model
International Journal of Molecular Sciences Article Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes within an Inflammation Model Alexander Otahal 1,* , Karina Kramer 1, Olga Kuten-Pella 2 , Lukas B. Moser 1, Markus Neubauer 1, Zsombor Lacza 2,3, Stefan Nehrer 1 and Andrea De Luna 1 1 Center for Regenerative Medicine, Danube University Krems, 3500 Krems, Austria; [email protected] (K.K.); [email protected] (L.B.M.); [email protected] (M.N.); [email protected] (S.N.); [email protected] (A.D.L.) 2 OrthoSera GmbH, 3500 Krems, Austria; [email protected] (O.K.-P.); [email protected] (Z.L.) 3 Institute of Sport and Health Sciences, University of Physical Education, 1123 Budapest, Hungary * Correspondence: [email protected] Abstract: Osteoarthritis (OA) is hallmarked by a progressive degradation of articular cartilage. One major driver of OA is inflammation, in which cytokines such as IL-6, TNF-α and IL-1β are secreted by activated chondrocytes, as well as synovial cells—including macrophages. Intra-articular injection of blood products—such as citrate-anticoagulated plasma (CPRP), hyperacute serum (hypACT), and extracellular vesicles (EVs) isolated from blood products—is gaining increasing importance in regenerative medicine for the treatment of OA. A co-culture system of primary OA chondrocytes and activated M1 macrophages was developed to model an OA joint in order to observe the effects Citation: Otahal, A.; Kramer, K.; of EVs in modulating the inflammatory environment. Primary OA chondrocytes were obtained from Kuten-Pella, O.; Moser, L.B.; patients undergoing total knee replacement. -
Total Joint Replacement Hip and Knee Pain Pinnacle Orthopedics Pinnacle Medical Network Total Joint Replacement
Total Joint Replacement Hip and Knee Pain Pinnacle Orthopedics Pinnacle Medical Network Total Joint Replacement About Pinnacle Orthopedics and Pinnacle Medical Network South Louisiana’s Premier System for the Delivery of Musculoskeletal Health Care. Our talented team and professional staff offer a fully- equipped facility for the comprehensive care of your bones, joints, ligaments and muscles. Our team is dedicated to your complete care, from assessment to full recovery. Our primary goal is your safe return to work, sports, play and the activities of daily living. Allow our medical professionals to advance your orthopedic care. Total Joint Replacement “It would be embarrassing to get out of a car because everybody had to help me. Somebody would have to pull me up. I felt like this old woman.” “My life got progressively less active, less fun, and less participative.” “Just a day on my feet was exhausting and the pain became greater and greater until Advil and ibuprofen and all of those kinds of drugs couldn't numb it out. It just got worse and worse.” Total Joint Replacement Does this sound familiar? Total Joint Replacement You’re Not Alone More than 43 million people have some form of arthritis. It is estimated that the number of people affected by arthritis will increase to 60 million by 2020. Source: CDC Total Joint Replacement This information will touch upon the following topics: Understanding the Causes of Joint Pain Treatment Options What Joint Replacement Surgery Involves Realistic Expectations After Joint Replacement Total Joint Replacement Total Joint Replacement Total Joint Replacement Did you know? Nearly 21 million Americans suffer from osteoarthritis, a degenerative joint disease that is a leading cause of joint replacement surgery. -
Knee Arthrodesis After Failed Total Knee Arthroplasty
650 COPYRIGHT Ó 2019 BY THE JOURNAL OF BONE AND JOINT SURGERY,INCORPORATED Current Concepts Review Knee Arthrodesis After Failed Total 04/12/2019 on 1mhtSo9F6TkBmpGAR5GLp6FT3v73JgoS8Zn360/N4fAEQXu6c15Knc+cXP2J5+wvbQY2nVcoOF2DIk3Zd0BSqmOXRD8WUDFCPOJ9CnEHMNOmtIbs3S0ykA== by http://journals.lww.com/jbjsjournal from Downloaded Knee Arthroplasty Downloaded Asim M. Makhdom, MD, MSc, FRCSC, Austin Fragomen, MD, and S. Robert Rozbruch, MD from http://journals.lww.com/jbjsjournal Investigation performed at the Hospital for Special Surgery, Weill Cornell Medicine, Cornell University, New York, NY ä Knee arthrodesis after failure of a total knee arthroplasty (TKA) because of periprosthetic joint infection (PJI) may provide superior functional outcome and ambulatory status compared with above-the-knee amputation. by 1mhtSo9F6TkBmpGAR5GLp6FT3v73JgoS8Zn360/N4fAEQXu6c15Knc+cXP2J5+wvbQY2nVcoOF2DIk3Zd0BSqmOXRD8WUDFCPOJ9CnEHMNOmtIbs3S0ykA== ä The use of an intramedullary nail (IMN) for knee arthrodesis following removal of TKA components because of a PJI may result in higher fusion rates compared with external fixation devices. ä The emerging role of the antibiotic cement-coated interlocking IMN may expand the indications to achieve knee fusion in a single-stage intervention. ä Massive bone defects after failure of an infected TKA can be managed with various surgical strategies in a single- stage intervention to preserve leg length and function. Primary total knee arthroplasty (TKA) is a common procedure suppressive antibiotics for recurrent PJIs are generally reserved with a reported increase of 162% from 1991 to 2010 in the for patients with more severe preoperative disability and United States1,2. From 2005 to 2030, it is projected that the medical comorbidity and those who are not candidates to number of TKA procedures will grow by 673% or 3.5 million. -
Hip Replacement/Arthroplasty Effective March 15, 2020
Cigna Medical Coverage Policies – Musculoskeletal Hip Replacement/Arthroplasty Effective March 15, 2020 Instructions for use The following coverage policy applies to health benefit plans administered by Cigna. Coverage policies are intended to provide guidance in interpreting certain standard Cigna benefit plans and are used by medical directors and other health care professionals in making medical necessity and other coverage determinations. Please note the terms of a customer’s particular benefit plan document may differ significantly from the standard benefit plans upon which these coverage policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a coverage policy. In the event of a conflict, a customer’s benefit plan document always supersedes the information in the coverage policy. In the absence of federal or state coverage mandates, benefits are ultimately determined by the terms of the applicable benefit plan document. Coverage determinations in each specific instance require consideration of: 1. The terms of the applicable benefit plan document in effect on the date of service 2. Any applicable laws and regulations 3. Any relevant collateral source materials including coverage policies 4. The specific facts of the particular situation Coverage policies relate exclusively to the administration of health benefit plans. Coverage policies are not recommendations for treatment and should never be used as treatment guidelines. This evidence-based medical coverage policy has been developed by eviCore, Inc. Some information in this coverage policy may not apply to all benefit plans administered by Cigna. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA).